Atlas Trials

Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1

RecordFirmDate
Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia (NCT01870596)National Cancer Institute (NCI)2013-05-01
Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia (NCT01361464)National Cancer Institute (NCI)2011-05-01
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia (NCT01260714)National Cancer Institute (NCI)2010-12-01
Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia (NCT01132586)National Cancer Institute (NCI)2010-05-01
Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase (NCT00383474)National Cancer Institute (NCI)2006-08-01
Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia (NCT00313586)National Cancer Institute (NCI)2006-08-01
Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases (NCT00351975)National Cancer Institute (NCI)2006-06-01
Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia (NCT00217646)National Cancer Institute (NCI)2005-10-01
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00105001)Fred Hutchinson Cancer Center2004-11-01

Track Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 automatically

Every clearance here is in the API, with alerts when new ones post.